Health & Biotechnology

Projects Establishment(s) IP Actions

(Français) VACCIN EHRLICHIOSES

(Français) VACCIN ATTENUE CONTRE LES EHRLICHIOSES

(Français) Centre de coopération International en Recherche Agronomique pour le Développement (CIRAD) (Français) Brevet

PL-VAC

(Français) PAN-LEISHMANIASIS PROPHYLACTIC HUMAN VACCINE

(Français) IRD, CIRAD, Institut Pasteur de Tunis (Français) Brevet

LipoSTAR

(Français) COMPOSÉS LIPOPHÉNOLIQUES DANS LA MALADIE DE STARGARDT ET AUTRES PATHOLOGIES ASSOCIÉES À UN STRESS OXYDANT ET CARBONYLÉ

(Français) HU Montpellier, Inserm, UM, CNRS, Université d’Auvergne (Français) Brevet

(Français) SFATI

(Français) AUTOMATISATION ET INDUSTRIALISATION D’UN NOUVEL ALGORITHME DE TRAITEMENT DES SIGNAUX OSCILLOMÉTRIQUES

(Français) UM et CHU de Nîmes (Français) Logiciel

3D-CELLS

(Français) DISPOSITIF INNOVANT DE CULTURE CELLULAIRE EN 3 DIMENSIONS

(Français) CNRS, UM, ENSCM, INSERM (Français) Brevet

SPIMA PROJECT

(Français) Développement de peptides agrafés pour le traitement des maladies inflammatoires

(Français) UM, CHU Montpellier, INSERM, CNRS Patent

NODIA

nNOS/PIN interaction inhibitors for diabetes type 2 treatment

BC2M: Cardiometabolic biocommunication N/A

DIVINS

Innovative implantable medical device for endovascular treatment of cerebral aneurysms

Montpellier CHU – UM - CNRS Patent

EPIDROP

Microfluid system to sort, characterize, and select ctc isolated in droplets

CHU, Laboratoire Chimie Biologie Innovation, CNRS, ESPCI (Paris Higher School of Industrial Physics and Chemistry), UPMC (University Pierre and Marie Curie), and University of Montpellier Patent

INHIBITORS OF TCPases

Development of a new class of therapeutic molecules to modulate TCPases

CNRS, University of Montpellier Patent

INTEGRACELLS

Non-invasive quality control test for pluripotent stem cells

INSERM, Montpellier CHU, University of Montpellier Patent

Vaccine against the disease of Newcastle

New vaccine against newcastle disease for clinical protection and to prevent excretion

CIRAD INRA Patent

P42

Preclinical development of P42 peptide, orphan drug for Huntington’s disease

University of Montpellier,Inserm, CNRS, EPHE Patent

TELE-MOUV

Development of a medically validated remote rehabilitation solution to improve the prevention and handling of chronic diseases. Non-drug therapies, structured physical activity, and nutrition are personalized and adapted in real-time by leveraging connected objects and specially-developed algorithms.

INSERM, CNRS, University of Montpellier N/A

PHLEBOSTHENE PROJECT

Complete system for body volumetrics and quantitative study of biomechanical parameters in human member veins, enabling personalized configuration of compression treatments for venous insufficiency and lymphedema.

University of Montpellier, CNRS, CHRU Montpellier, CHU Nîmes Patent

ANTISYN

Design of a medical device that is bioresorbable, anti-adhesion, and self-deploying, adapted for an endo-uterine approach, to prevent the development of intra-uterine synechia in order to regain fertility spontaneously

Department of Artificial Biopolymers at the Max Mousseron Biomolecule Institute (CNRS - University of Montpellier (UM) - ENSCM), Obstetric Gynecology Department (CHU Nîmes, UM) Patent

AVIITAM

AVIITAM enables doctors to continue their professional development while still seeing patients, allowing them to implement lifestyle-oriented health care for treating chronic diseases.

CHRU Montpellier N/A

COMET, BUILDING A METABOLIC TISSUE DATABASE

Constitution, qualification, and use of a database of tissues from type 2 diabetes patients for industry and academic partners.

University of Montpellier, Montpellier CHRU N/A

DOCK 5

Development of new compounds to treat pathologies related to bone loss (hyperresorption).

CNRS, University of Montpellier Patent

SMART BIO DRESSING PROJECT

A new family of biomolecule-based materials for creating smart dressings, bio-mimetic matrices, and for drug targeting and vectorization, and imaging.

University of Montpellier, CNRS, Montpellier National Higher School of Chemistry (ENSCM) Patents